These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 16791836

  • 1. Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever.
    Fink J, Gu F, Vasudevan SG.
    Rev Med Virol; 2006; 16(4):263-75. PubMed ID: 16791836
    [Abstract] [Full Text] [Related]

  • 2. T lymphocyte responses to heterologous secondary dengue virus infections.
    Rothman AL.
    Ann N Y Acad Sci; 2009 Sep; 1171 Suppl 1():E36-41. PubMed ID: 19751400
    [Abstract] [Full Text] [Related]

  • 3. Immunopathological mechanisms in dengue and dengue hemorrhagic fever.
    Green S, Rothman A.
    Curr Opin Infect Dis; 2006 Oct; 19(5):429-36. PubMed ID: 16940865
    [Abstract] [Full Text] [Related]

  • 4. Dengue hemorrhagic fever with special emphasis on immunopathogenesis.
    Kurane I.
    Comp Immunol Microbiol Infect Dis; 2007 Sep; 30(5-6):329-40. PubMed ID: 17645944
    [Abstract] [Full Text] [Related]

  • 5. Antibodies from dengue patient sera cross-react with endothelial cells and induce damage.
    Lin CF, Lei HY, Shiau AL, Liu CC, Liu HS, Yeh TM, Chen SH, Lin YS.
    J Med Virol; 2003 Jan; 69(1):82-90. PubMed ID: 12436482
    [Abstract] [Full Text] [Related]

  • 6. Dengue viral infections.
    Malavige GN, Fernando S, Fernando DJ, Seneviratne SL.
    Postgrad Med J; 2004 Oct; 80(948):588-601. PubMed ID: 15466994
    [Abstract] [Full Text] [Related]

  • 7. Understanding dengue pathogenesis: implications for vaccine design.
    Stephenson JR.
    Bull World Health Organ; 2005 Apr; 83(4):308-14. PubMed ID: 15868023
    [Abstract] [Full Text] [Related]

  • 8. Dengue and dengue haemorrhagic fever: implications of host genetics.
    Chaturvedi U, Nagar R, Shrivastava R.
    FEMS Immunol Med Microbiol; 2006 Jul; 47(2):155-66. PubMed ID: 16831202
    [Abstract] [Full Text] [Related]

  • 9. Cross-reactive T-cell responses to the nonstructural regions of dengue viruses among dengue fever and dengue hemorrhagic fever patients in Malaysia.
    Appanna R, Huat TL, See LL, Tan PL, Vadivelu J, Devi S.
    Clin Vaccine Immunol; 2007 Aug; 14(8):969-77. PubMed ID: 17567768
    [Abstract] [Full Text] [Related]

  • 10. Alternate hypothesis on the pathogenesis of dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS) in dengue virus infection.
    Noisakran S, Perng GC.
    Exp Biol Med (Maywood); 2008 Apr; 233(4):401-8. PubMed ID: 18367628
    [Abstract] [Full Text] [Related]

  • 11. Cross-reactive memory CD8(+) T cells alter the immune response to heterologous secondary dengue virus infections in mice in a sequence-specific manner.
    Beaumier CM, Mathew A, Bashyam HS, Rothman AL.
    J Infect Dis; 2008 Feb 15; 197(4):608-17. PubMed ID: 18275279
    [Abstract] [Full Text] [Related]

  • 12. Immunopathogenesis of Dengue hemorrhagic fever.
    Rothman AL, Ennis FA.
    Virology; 1999 Apr 25; 257(1):1-6. PubMed ID: 10208914
    [No Abstract] [Full Text] [Related]

  • 13. Anti-dengue virus nonstructural protein 1 antibodies recognize protein disulfide isomerase on platelets and inhibit platelet aggregation.
    Cheng HJ, Lei HY, Lin CF, Luo YH, Wan SW, Liu HS, Yeh TM, Lin YS.
    Mol Immunol; 2009 Dec 25; 47(2-3):398-406. PubMed ID: 19822367
    [Abstract] [Full Text] [Related]

  • 14. Implications of previous subclinical dengue infection but not virus load in dengue hemorrhagic fever.
    Yeh WT, Chen RF, Wang L, Liu JW, Shaio MF, Yang KD.
    FEMS Immunol Med Microbiol; 2006 Oct 25; 48(1):84-90. PubMed ID: 16965355
    [Abstract] [Full Text] [Related]

  • 15. Elevated levels of total and dengue virus-specific immunoglobulin E in patients with varying disease severity.
    Koraka P, Murgue B, Deparis X, Setiati TE, Suharti C, van Gorp EC, Hack CE, Osterhaus AD, Groen J.
    J Med Virol; 2003 May 25; 70(1):91-8. PubMed ID: 12629649
    [Abstract] [Full Text] [Related]

  • 16. Quantitation of T lymphocyte subsets helps to distinguish dengue hemorrhagic fever from classic dengue fever during the acute febrile stage.
    Fadilah SA, Sahrir S, Raymond AA, Cheong SK, Aziz JA, Sivagengei K.
    Southeast Asian J Trop Med Public Health; 1999 Dec 25; 30(4):710-7. PubMed ID: 10928365
    [Abstract] [Full Text] [Related]

  • 17. Dengue and dengue hemorrhagic fever among adults: clinical outcomes related to viremia, serotypes, and antibody response.
    Guilarde AO, Turchi MD, Siqueira JB, Feres VC, Rocha B, Levi JE, Souza VA, Boas LS, Pannuti CS, Martelli CM.
    J Infect Dis; 2008 Mar 15; 197(6):817-24. PubMed ID: 18269315
    [Abstract] [Full Text] [Related]

  • 18. Differences in global gene expression in peripheral blood mononuclear cells indicate a significant role of the innate responses in progression of dengue fever but not dengue hemorrhagic fever.
    Ubol S, Masrinoul P, Chaijaruwanich J, Kalayanarooj S, Charoensirisuthikul T, Kasisith J.
    J Infect Dis; 2008 May 15; 197(10):1459-67. PubMed ID: 18444802
    [Abstract] [Full Text] [Related]

  • 19. Progress for dengue virus diseases. Towards the NS2B-NS3pro inhibition for a therapeutic-based approach.
    Melino S, Paci M.
    FEBS J; 2007 Jun 15; 274(12):2986-3002. PubMed ID: 17509079
    [Abstract] [Full Text] [Related]

  • 20. Immunity and immunopathology in dengue virus infections.
    Kurane I, Ennis FE.
    Semin Immunol; 1992 Apr 15; 4(2):121-7. PubMed ID: 1617166
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.